X.-G. Li, L. T. Kanerva / Tetrahedron: Asymmetry 16 (2005) 1709–1714
1713
14.17 Hz, 1H, indole-CH2); 2.93–2.97 (dd, J = 5.37,
14.18 Hz, 1H, indole-CH2); 3.60–3.62 (m, 1H, CHNH2);
4.12–4.16 (q, J = 7.13 Hz, 2H, CO2CH2CH3); 7.07 (s, 1
arom. H); 7.11–7.14 (t, J = 7.49 Hz, 1 arom. H); 7.19–
1.24–1.27 (t, J = 7.12 Hz, 3H, CO2CH2CH3); 1.57–1.64
(m, 2H, COCH2CH2CH3); 2.10–2.13 (t, J = 7.34 Hz,
2H, COCH2CH2CH3); 2.47–2.51 (dd, J = 4.58,
16.00 Hz, 1H, CHCH2CO2); 2.52–2.56 (dd, J = 4.37,
16.58 Hz, 1H, CHCH2CO2); 2.97–3.02 (dd, J = 7.83,
14.54 Hz, 1H, indole-CH2); 3.08–3.12 (dd, J = 5.87,
14.54 Hz, 1H, indole-CH2); 4.12–4.16 (q, J = 7.11 Hz,
2H, CO2CH2CH3); 4.60–4.67 (m, 1H, CHNHCO);
7.22 (t, J = 7.65 Hz,
1 arom. H); 7.36–7.38 (d,
J = 8.10 Hz, 1 arom. H); 7.62–7.64 (d, J = 7.88 Hz, 1
arom. H); 8.14 (br s, 1H, NH). 13C NMR (CDCl3,
126 MHz): d = 14.18 (CH3), 32.41 (indole-CH2), 40.99
(CH2CO2), 48.70 (CHNH2), 60.45 (CO2CH2CH3),
111.18, 112.53, 119.00, 119.50, 122.16, 122.82, 127.57,
136.38, 172.62 (CO2).
7.03 (d, J = 2.20 Hz,
1 arom. H); 7.10–7.13 (t,
J = 7.78 Hz, 1 arom. H); 7.17–7.20 (t, J = 8.03 Hz, 1
arom. H); 7.35–7.37 (d, J = 8.12 Hz, 1 arom. H); 7.64–
7.66 (d, J = 7.87 Hz, 1 arom. H); 8.29 (br s, 1 H, NH).
13C NMR (CDCl3, 126 MHz): d = 13.65 (COCH2-
CH2CH3), 14.18 (CO2CH2CH3), 19.07 (COCH2-
CH2CH3), 29.48 (indole-CH2), 37.40 (CHCH2CO2),
38.83 (COCH2CH2CH3); 46.70 (CHCH2CO2), 60.67
(CO2CH2CH3); 111.18, 111.62, 118.89, 119.56, 122.11,
122.82, 127.72, 136.23, 172.21 (CO2CH2CH3), 172.76
(COCH2CH2CH3).
4.6. Gram-scale resolution of rac-4
CAL-A preparation (20 mg/mL) was added to a solu-
tion of racemic 4 (1.00 g, 5.02 mmol) in PrCO2Bu/DIPE
(1:1) (100 mL). The reaction was stopped at 51% conver-
sion by filtering off the enzyme. The filtrate was evapo-
rated and the residue purified on silica gel eluting with
dichloromethane/methanol (19:1), affording (S)-4,
20
D
CHCl3) and semi-solid (R)-7, 0.67 g, 2.49 mmol,
0.47 g, 2.38 mmol, ee = 99% and ½a ¼ þ15:0 (c 0.9,
20
4.8. Preparation of rac-3-(1H-3-indolyl)-2-(tosylamino)-
propyl toluene-4-sulfonate 8
ee = 95%, ½a ¼ þ32:5 (c 0.9, CHCl3). Spectral data
D
for (R)-7: HRMS: M+ found (M+ calculated for
C16H19N3O): 269.15260 (269.15281); MS: m/z (relative
intensity) = 269 (12), 182 (90), 130 (100), 103 (7), 77
(9); 1H NMR (CDCl3, 500 MHz): d = 0.89–0.92 (t,
J = 7.39 Hz, 3H, CH3); 1.59–1.66 (m, 2H, CH2CH3);
2.14–2.17 (t, J = 7.34 Hz, 2H, COCH2); 2.47–2.51 (dd,
J = 4.20, 16.77 Hz, 1H, CH2CN); 2.73–2.77 (dd, J =
5.48, 16.77 Hz, 1H, CH2CN); 3.05–3.09 (dd, J = 8.26,
14.61 Hz, 1H, indole-CH2); 3.15–3.19 (dd, J = 6.20,
14.61 Hz, 1H, indole-CH2); 4.45–4.54 (m, 1H,
CHNHCO); 5.80 (br s, 1H, NH); 7.11–7.16 (m, 2 arom.
H); 7.21–7.24 (t, J = 7.21 Hz, 1 arom. H); 7.34–7.39 (d,
J = 8.13 Hz, 1 arom. H); 7.62–7.63 (d, J = 7.91 Hz, 1
arom. H); 8.34 (br s, 1 H). 13C NMR (CDCl3,
126 MHz): d = 13.65 (CH3), 19.00 (CH2CH3), 22.26
(CH2CN), 28.92 (indole-CH2), 38.53 (COCH2), 46.29
(CHNHCO), 110.09, 111.48, 117.63, 118.50, 119.99,
122.57, 123.06, 127.14, 136.38, 173.20 (NHCO).
Compound 8 was prepared at 85% yield by the known
method.8 1H NMR (CDCl3, 500 MHz): d = 2.32 (s,
3H, CH3); 2.44 (s, 3H, CH3); 2.77–2.82 (dd, J = 6.98,
14.63 Hz, 1H, indole-CH2); 2.98–3.02 (dd, J = 7.00,
14.63 Hz, 1H, indole-CH2); 3.57–3.64 (m, 1H, indole-
CH2CH); 3.87–3.90 (dd, J = 5.65, 9.97 Hz, 1H, CH2O-
SO2); 4.08–4.11 (dd, J = 4.42, 9.98 Hz, 1H, CH2OSO2);
6.88–6.89 (d, J = 2.32 Hz, 1 arom. H); 6.95–6.98 (dt,
J = 0.84, 7.87 Hz,
1
arom. H); 7.01–7.03 (d,
J = 8.07 Hz, 2 arom. H); 7.12–7.18 (m, 2 arom. H);
7.27–7.29 (d, J = 8.14 Hz, 1 arom. H); 7.31–7.33 (d,
J = 8.01 Hz, 2 arom. H); 7.43–7.45 (d, J = 8.29 Hz, 2
arom. H); 7.74–7.76 (d, J = 8.31 Hz, 2 arom. H); 8.16
(br s, 1H, NH). 13C NMR (CDCl3, 126 MHz):
d = 21.52 (CH3), 21.69 (CH3), 27.32 (indole-CH2),
52.13 (indole-CH2CH), 70.60 (CH2OSO2), 109.39,
111.30, 118.23, 119.62, 122.15, 123.45, 126.75, 128.01,
129.45, 130.00, 132.31, 136.21, 136.29, 143.38, 145.19.
The obtained (S)-4 was transformed to (S)-5 at 60%
20
D
yield, ½a ¼ ꢀ5:4 (c 1.0, CHCl3), ee = 99% and (R)-7
Acknowledgements
20
to (R)-5 at 63% yield, ½a ¼ þ5:2 (c 1.0, CHCl3),
D
ee = 95% as described above.
The authors thank the Academy of Finland for financial
support (grant 75267 to L.K.).
4.7. Gram-scale resolution of rac-5
CAL-A preparation (20 mg/mL) was added to the solu-
tion of racemic 5 (1.00 g, 4.07 mmol) in PrCO2Bu/DIPE
(1:1) (81 mL). The reaction was stopped at 50% conver-
sion by filtering off the enzyme. The filtrate was evapo-
rated and the residue purified on silica gel eluting with
References
1. Juaristi, E. Enantioselective Synthesis of b-Amino Acids;
Wiley-VHC: New York, 1997.
2. Steer, D. L.; Lew, R. A.; Perlmutter, P.; Smith, A. I.;
Aguilar, M.-I. Curr. Med. Chem. 2002, 9, 811–822.
3. Seebach, D.; Kimmerlin, T.; Sebesta, R.; Campo, M. A.;
Beck, A. K. Tetrahedron 2004, 60, 7455–7506.
4. Rodionov, W. M.; Malivinskaya, E. Th. Chem. Ber. 1926,
59, 2952–2958.
5. Cimarelli, C.; Palmieri, G. J. Org. Chem. 1996, 61, 5557–
5563.
6. Cohen, J. H.; Abdel-Magid, A. F.; Almond, H. R., Jr.;
Maryanoff, C. A. Tetrahedron Lett. 2002, 43, 1977–
1981.
dichloromethane/methanol (19:1), affording (S)-5,
20
D
CHCl3), and semi-solid (R)-6, 0.62 g, 1.96 mmol,
0.48 g, 1.95 mmol, ee >99% and ½a ¼ ꢀ5:4 (c 1.0,
20
ee >99%, ½a ¼ þ8:0 (c 1.0, CHCl3). Spectral data for
D
(R)-6: HRMS: M+ found (M+ calculated for
C18H24N2O3): 316.17860 (316.17869); MS: m/z (relative
intensity) = 316 (11), 229 (100), 184 (10), 156 (31), 143
1
(15), 130 (50), 116 (27); H NMR (CDCl3, 500 MHz):
d = 0.88–0.91 (t, J = 7.39 Hz, 3H, COCH2CH2CH3);